Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Benefit-risk analysis: a proposal using quantitative methods.

William L Holden¹, Juhaeri Juhaeri, Wanju Dai

¹Aventis Pharmaceuticals, Bridgewater, NJ, USA. William.Holden@aventis.com

Pharmacoepidemiology and Drug Safety

|October 16, 2003

Summary

This study introduces quantitative methods for benefit-risk analysis, including adjusted number-needed-to-treat (NNT) and minimum clinical efficacy (MCE) analysis. These approaches aim to simplify complex data into a single metric for better risk management decisions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Methodological comparisons for benefit-risk assessment in complex decision-making: applications and insights from a case study.

Frontiers in drug safety and regulation·2026

Same author

Evaluating effectiveness of risk minimization through healthcare professional surveys: A review of post-authorization studies, 2022-2024.

British journal of clinical pharmacology·2026

Same author

Discrete Choice Experiment (DCE) as a Tool to Elicit Patient Preferences in a Complex Benefit-Risk Evaluation: A Case Study.

Clinical drug investigation·2026

Same author

Real-World Data and Real-World Evidence in Regulatory Decision Making: Report Summary From the Council for International Organizations of Medical Sciences (CIOMS) Working Group XIII.

Pharmacoepidemiology and drug safety·2025

Same author

Evaluating the Accuracy of Responses by Large Language Models for Information on Disease Epidemiology.

Pharmacoepidemiology and drug safety·2025

Same author

Application of a Language Model Tool for COVID-19 Vaccine Adverse Event Monitoring Using Web and Social Media Content: Algorithm Development and Validation Study.

JMIR infodemiology·2024

Area of Science:

Pharmacoeconomics
Quantitative Health Sciences
Risk Management

Background:

Benefit-risk analysis is crucial for product development and regulatory decision-making.
Current methods may not adequately synthesize complex benefit-risk profiles.
Improved quantitative tools are needed for clearer communication among stakeholders.

Purpose of the Study:

To introduce novel quantitative methods for benefit-risk analysis.
To present adjustments to number-needed-to-treat (NNT) analysis.
To introduce and critically discuss minimum clinical efficacy (MCE) analysis.

Main Methods:

The study proposes quantitative methods for benefit-risk assessment.
Adjustments to existing NNT analysis are detailed.

Related Experiment Videos

A new MCE analysis framework is presented.

Main Results:

The proposed methods aim to condense benefit-risk profiles into summary metrics.
These metrics facilitate a better understanding of product safety and efficacy.
The methods are designed for use by manufacturers, regulators, clinicians, and patients.

Conclusions:

Quantitative benefit-risk analysis can be enhanced through novel methods like MCE.
Simplified summary metrics improve stakeholder participation in risk management.
This work lays the foundation for practical application in a subsequent article.